BRAT1 - a new therapeutic target for glioblastoma
Authors:
- Alicia HaydoAHAlicia Haydo
- Jennifer SchmidtJSJennifer Schmidt
- Alisha CriderACAlisha Crider
- Tim KöglerTKTim Kögler
- Johanna ErtlJEJohanna Ertl
- Stephanie HehlgansSHStephanie Hehlgans
- Marina E. HoffmannMHMarina E. Hoffmann
- Rajeshwari RathoreRRRajeshwari Rathore
- Ömer GüllülüÖGÖmer Güllülü
- Yecheng WangYWYecheng Wang
- Xiangke ZhangXZXiangke Zhang
- Christel Herold-MendeCHChristel Herold-Mende
Open Access
- 21 January 2025
- journal article
- research article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 82 (1) , 1-23
Abstract
Glioblastoma (GBM), the most malignant primary brain tumor in adults, has poor prognosis irrespective of therapeutic advances due to its radio-resistance and infiltrative growth into brain tissue. The present study assessed functions and putative druggability of BRCA1-associated ATM activator 1 (BRAT1) as a crucial factor driving key aspects of GBM, including enhanced DNA damage response and tumor migration. By a stable depletion of BRAT1 in GBM and glioma stem-like (GSC) cell lines, we observed a delay in DNA double-strand break repair and increased sensitivity to radiation treatment, corroborated by in vitro and in vivo studies demonstrating impaired tumor growth and invasion. Proteomic and phosphoproteomic analyses further emphasize the role of BRAT1’s cell migration and invasion capacity, with a notable proportion of downregulated proteins associated with these processes. In line with the genetic manipulation, we found that treatment with the BRAT1 inhibitor Curcusone D (CurD) significantly reduced GSC migration and invasion in an ex vivo slice culture model, particularly when combined with irradiation, resulting in a synergistic inhibition of tumor growth and infiltration. Our results reveal that BRAT1 contributes to GBM growth and invasion and suggest that therapeutic inhibition of BRAT1 with CurD or similar compounds might constitute a novel approach for anti-GBM directed treatments.Keywords
All Related Versions
Funding Information
- Universitätsklinikum Frankfurt
This publication has 85 references indexed in Scilit:
- BAG3 regulates cilia homeostasis of glioblastoma via its WW domainBioFactors, 2024
- BAG3 is a negative regulator of ciliogenesis in glioblastoma and triple‐negative breast cancer cellsJournal of Cellular Biochemistry, 2021
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summaryActa Neuropathologica, 2016
- PAK1 mediates pancreatic cancer cell migration and resistance to MET inhibitionThe Journal of Pathology, 2014
- Using the molecular classification of glioblastoma to inform personalized treatmentThe Journal of Pathology, 2013
- High-resolution deep imaging of live cellular spheroids with light-sheet-based fluorescence microscopyCell and tissue research, 2013
- Overexpression of Snail induces epithelial–mesenchymal transition and a cancer stem cell–like phenotype in human colorectal cancer cellsCancer Medicine, 2012
- Individual and combined soy isoflavones exert differential effects on metastatic cancer progressionClinical & Experimental Metastasis, 2010
- Pharmacological inhibition of Bcl-2 family members reactivates TRAIL-induced apoptosis in malignant gliomaJournal of Neuro-Oncology, 2007
- Diffuse glioma growth: a guerilla warActa Neuropathologica, 2007